MedPath
HSA Approval

TEPADINA POWDER AND SOLVENT FOR SOLUTION FOR INFUSION 400MG

SIN17095P

TEPADINA POWDER AND SOLVENT FOR SOLUTION FOR INFUSION 400MG

TEPADINA POWDER AND SOLVENT FOR SOLUTION FOR INFUSION 400MG

September 20, 2024

AXXESSBIO PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAXXESSBIO PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

L01AC01

Manufacturer Information

AXXESSBIO PTE. LTD.

Nerpharma S.R.L.

ADIENNE S.r.l. S.U.

Active Ingredients

Thiotepa

400mg

Thiotepa

Documents

Package Inserts

Tepadina 400mg preparation guide.pdf

Approved: September 20, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TEPADINA POWDER AND SOLVENT FOR SOLUTION FOR INFUSION 400MG - HSA Approval | MedPath